Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer
Overview
Authors
Affiliations
Aim: The aim of this study was to examine the clinicopathological influence of tumor-infiltrating cluster of differentiation (CD) 163 macrophages and CD8 T-cells, and to clarify the prognostic effects of these cells in patients with invasive extrahepatic bile duct cancer (EHBC).
Materials And Methods: The numbers of CD8 T-cells in cancer cell nests and CD163 macrophages in tumor stroma were evaluated using immunohistochemistry in 101 resected EHBC specimens. Correlations with clinicopathological variables and overall survival were analyzed.
Results: Perihilar EHBC and perineural invasion were significantly associated with a low number of tumor-infiltrating CD8 T-cells. Poorly- differentiated histology and nodal metastasis were significantly associated with a high number of tumor-infiltrating CD163 macrophages. A combination of high number of CD8 T-cells and low number of CD163 macrophages was independently related to better overall survival in the whole patient cohort (hazard ratio=0.127, p<0.001) and in patients treated with adjuvant chemotherapy (hazard ratio=0.139, p=0.021).
Conclusion: Infiltrating CD163 macrophages in tumor stroma and CD8 T-cells in cancer cell nests have a prognostic impact in patients with EHBC following resection and also after adjuvant chemotherapy.
The Immune-Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies.
Cammarota A, Balsano R, Pressiani T, Bozzarelli S, Rimassa L, Lleo A Cancers (Basel). 2025; 17(2).
PMID: 39858054 PMC: 11763448. DOI: 10.3390/cancers17020272.
Choi J, Kim J, Lee K, Lee G, Hong M, Hwang H J Pers Med. 2024; 14(10).
PMID: 39452540 PMC: 11508419. DOI: 10.3390/jpm14101033.
Li X, Wang Y, Guan R, Sheng N, Zhang S Biology (Basel). 2024; 13(10).
PMID: 39452125 PMC: 11504529. DOI: 10.3390/biology13100816.
Shi H, Li Z, Zhu M Curr Med Chem. 2024; 32(3):595-607.
PMID: 38698750 DOI: 10.2174/0109298673296618240424095548.
Effect of 2-methoxyestradiol on mammary tumor initiation and progression.
Peta K, Durandt C, van Heerden M, Joubert A, Pepper M, Ambele M Cancer Rep (Hoboken). 2024; 7(4):e2068.
PMID: 38600057 PMC: 11006714. DOI: 10.1002/cnr2.2068.